Neurologic Disease in Australian Shepherds: Two Real Threads

Epilepsy is a documented health issue for Australian Shepherds, referring to recurrent seizures caused by abnormal electrical activity in the brain, most often with no other identifiable underlying disease once basic bloodwork and imaging rule out other causes (this is sometimes called idiopathic epilepsy). Seizures typically first appear between about one and five years old, and can range from brief, subtle episodes to more dramatic, whole-body convulsions.

A single isolated seizure is frightening but doesn't necessarily mean a lifelong epilepsy diagnosis — the pattern over time (frequency, whether seizures cluster together, how they respond to any treatment) is what actually shapes both the diagnosis and the long-term management plan a vet or veterinary neurologist would recommend.

The MDR1 gene mutation, documented for this breed as sensitivity to ivermectin, affects a protein that normally acts as a pump, keeping certain drugs out of the brain by pushing them back out of brain tissue. In a dog with the mutation, that pump doesn't work properly, so drugs that would normally stay largely out of the brain in an unaffected dog can cross into it and build up, sometimes causing serious neurological toxicity — tremors, disorientation, or more severe effects depending on the specific drug and dose involved.

This is precisely why MDR1 status matters for more than just one specific medication: it's relevant any time a vet is choosing among several possible drugs, including certain treatments that might otherwise be considered for managing a seizure disorder. A dog known to have epilepsy and known to carry the MDR1 mutation is exactly the kind of case where both pieces of information genuinely change how a vet approaches treatment planning together, rather than as two separate, unrelated facts.